NCT06296381 Normative Values for Peripheral Muscle Strength in Critical Patients and Healthy Individuals
| NCT ID | NCT06296381 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Pernambuco |
| Condition | Intensive Care Unit |
| Study Type | OBSERVATIONAL |
| Enrollment | 180 participants |
| Start Date | 2024-03-01 |
| Primary Completion | 2026-07-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 180 participants in total. It began in 2024-03-01 with a primary completion date of 2026-07-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Muscle strength is an important indicator of overall health and is a factor that has been associated with increased mortality in critical patients. Its measurement must be reliable and reproducible to ensure a quality outcome for clinical applicability. Recently, the use of digital handheld dynamometers in intensive care has gained support; however, analysis becomes challenging due to the absence of standardized reference equations for the Brazilian population. The aim of this study is to develop reference equations for the Brazilian population and define specific cutoff points for men, women, healthy individuals, and critical patients.
Eligibility Criteria
Inclusion Criteria: * Healthy individuals of both sexes * Patients and volunteers aged between 18 and 90 years old (youth/adults/elderly). * Patients admitted to the ICU. * No recent muscle injuries of both limbs for a past 6-months. Exclusion Criteria: Patients and volunteers \< 20 years and \> 90 years Healthy individuals * Unable to follow command completely * Severe osteoporosis or neuromuscular disease leading to decreased muscle strength * Presence of opened or infectious wound * Presence of pain in evaluating muscle groups Patients in ICU * Unable to follow command completely * Acute stroke * Hip fracture, unstable cervical spine or pathological fracture * Recent surgery involving the upper airways, chest, abdomen, or limbs * Presence of opened or infectious wound * Presence of pain in evaluating muscle groups
Contact & Investigator
Pedro Vinicius Porfirio
PRINCIPAL INVESTIGATOR
University of Pernambuco
Frequently Asked Questions
Who can join the NCT06296381 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 90 Years, studying Intensive Care Unit. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06296381 currently recruiting?
Yes, NCT06296381 is actively recruiting participants. Contact the research team at shirley.campos@ufpe.br for enrollment information.
Where is the NCT06296381 trial being conducted?
This trial is being conducted at Recife, Brazil, Recife, Brazil, Recife, Brazil, Recife, Brazil.
Who is sponsoring the NCT06296381 clinical trial?
NCT06296381 is sponsored by University of Pernambuco. The principal investigator is Pedro Vinicius Porfirio at University of Pernambuco. The trial plans to enroll 180 participants.